{"id":21592,"date":"2024-11-27T15:19:28","date_gmt":"2024-11-27T15:19:28","guid":{"rendered":"https:\/\/makingpharmaindustry.it\/?p=21592"},"modified":"2024-12-03T16:26:07","modified_gmt":"2024-12-03T16:26:07","slug":"digital-therapeutics-the-next-frontier-in-chronic-disease-management","status":"publish","type":"post","link":"https:\/\/makingpharmaindustry.it\/en\/digital-health\/digital-therapies\/digital-therapeutics-the-next-frontier-in-chronic-disease-management\/","title":{"rendered":"Digital Therapeutics: the next frontier in chronic disease management"},"content":{"rendered":"

Chronic diseases account for a significant global health burden, with traditional management models proving unsustainable. Digital therapeutics (DTx) and health technologies are reshaping this landscape by empowering patients with advanced tools for self-management, monitoring, and treatment<\/strong>. In this article, we explore the transformative potential of these innovations, focusing on their mechanisms, research and development, and implications for the pharmaceutical industry.<\/p>\n

Chronic Disease Management: an unsustainable model<\/h2>\n

Chronic diseases, ranging from diabetes to hypertension and beyond, have escalated to global proportions. According to the World Health Organization, most patients with chronic conditions spend only about two hours a year with healthcare providers, leaving them to self-manage their health for the remaining 8,758 hours annually. This reliance on sporadic healthcare interaction underscores the need for solutions that integrate seamlessly into daily life.<\/p>\n

Digital health technologies<\/strong> (DHTs) provide the answer by delivering continuous support and personalized interventions, enabling patients to manage their conditions effectively outside clinical settings.<\/p>\n

The rise of Digital Health Technologies<\/h2>\n

Digital health technologies encompass patient-facing applications, healthcare provider (HCP)-facing tools, and industry or administrative solutions. Key categories include:<\/p>\n

    \n
  1. Patient Monitoring<\/strong>: Devices like continuous glucose monitors collect real-time data, offering insights into patient health and informing care plans.<\/li>\n
  2. Care Support Tools<\/strong>: Applications such as CLEO for multiple sclerosis help patients organize their care, manage symptoms, and adhere to medication regimens.<\/li>\n
  3. Digital Therapeutics (DTx)<\/strong>: Software-based interventions like cognitive-behavioral therapy or neurological stimulation target specific conditions to achieve measurable health outcomes.<\/li>\n<\/ol>\n

    Understanding Digital Therapeutics<\/h2>\n

    Digital therapeutics are distinct from other health technologies<\/strong> in their stringent regulatory requirements and evidence-based approach. Defined by the International Organization for Standardization (ISO), DTx involves software designed to treat, alleviate, or manage diseases through digital interventions<\/strong>. These include cognitive-behavioral therapy for insomnia or neurological stimulation for motor rehabilitation.<\/p>\n

    DTx solutions are integrated with traditional treatments, often enhancing or replacing pharmaceutical interventions. For example:<\/p>\n

      \n
    • Additive Therapy<\/strong>: Combining DTx with existing treatments (e.g., drug + DTx) to achieve superior outcomes.<\/li>\n
    • Alternative Therapy<\/strong>: Replacing standard drugs with a digital solution of equivalent efficacy.<\/li>\n
    • Combination Therapy<\/strong>: Pairing DTx with pharmaceuticals for synergistic benefits.<\/li>\n<\/ul>\n

      Research and Development in DTx<\/h2>\n

      The development pipeline for DTx mirrors that of traditional pharmaceuticals but with unique considerations:<\/p>\n

        \n
      • Preclinical and Clinical Trials<\/strong>: Rigorous testing ensures safety, efficacy, and regulatory compliance.<\/li>\n
      • Evidence Generation<\/strong>: Robust data supports claims of therapeutic benefit, distinguishing DTx from general wellness apps.<\/li>\n
      • Post-Market Surveillance<\/strong>: Continuous monitoring ensures sustained performance in real-world scenarios.<\/li>\n<\/ul>\n

        Key players in this sector, such as QK Digital and daVi DigitalMedicine, are advancing projects across hypertension, chronic insomnia, and motor rehabilitation, highlighting the scalability and versatility of DTx solutions.<\/p>\n

        Implications for the Pharmaceutical Industry<\/h2>\n

        The advent of digital therapeutics marks a paradigm shift for the pharmaceutical sector. Companies must adapt to new business models, integrating software-based therapies into their portfolios. Collaboration with tech startups, regulatory agencies, and healthcare providers will be crucial for success.<\/p>\n

        Additionally, the industry faces challenges, including:<\/p>\n

          \n
        • Navigating regulatory frameworks specific to DTx.<\/li>\n
        • Building evidence to support reimbursement and widespread adoption.<\/li>\n
        • Addressing patient and provider education to ensure effective implementation.<\/li>\n<\/ul>\n
          \n
          \n
          \n
          \n
          \n
          \n

          A digital revolution in healthcare<\/h2>\n

          Digital health technologies and therapeutics<\/strong> offer unprecedented opportunities to transform chronic disease management. By bridging gaps in traditional care models, these innovations empower patients, enhance outcomes, and create new pathways for the pharmaceutical industry to deliver value. As the sector evolves, embracing this digital revolution will be key to addressing the growing burden of chronic diseases globally.<\/p>\n

          References: https:\/\/www.eipg.eu\/webinars\/<\/em><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

          Chronic diseases account for a significant global health burden, with traditional management models proving unsustainable. Digital therapeutics (DTx) and health technologies are reshaping this landscape by empowering patients with advanced tools for self-management, monitoring, and treatment. In this article, we explore the transformative potential of these innovations, focusing on their mechanisms, research and development, and implications for the pharmaceutical industry.<\/p>\n","protected":false},"author":32,"featured_media":21588,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[803],"tags":[],"class_list":{"0":"post-21592","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-digital-therapies"},"yoast_head":"\nDigital Therapeutics: the next frontier in chronic disease management - MakingPharmaIndustry<\/title>\n<meta name=\"description\" content=\"Digital therapeutics (DTx) and health technologies are empowering patients with advanced tools for self-management, monitoring, and treatment\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/makingpharmaindustry.it\/en\/digital-health\/digital-therapies\/digital-therapeutics-the-next-frontier-in-chronic-disease-management\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Digital Therapeutics: the next frontier in chronic disease management - MakingPharmaIndustry\" \/>\n<meta property=\"og:description\" content=\"Digital therapeutics (DTx) and health technologies are empowering patients with advanced tools for self-management, monitoring, and treatment\" \/>\n<meta property=\"og:url\" content=\"https:\/\/makingpharmaindustry.it\/en\/digital-health\/digital-therapies\/digital-therapeutics-the-next-frontier-in-chronic-disease-management\/\" \/>\n<meta property=\"og:site_name\" content=\"MakingPharmaIndustry\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-27T15:19:28+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-03T16:26:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/12\/AdobeStock_1108713087-scaled.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1435\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Valentina Parrella\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Valentina Parrella\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/digital-health\/digital-therapies\/digital-therapeutics-the-next-frontier-in-chronic-disease-management\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/digital-health\/digital-therapies\/digital-therapeutics-the-next-frontier-in-chronic-disease-management\/\"},\"author\":{\"name\":\"Valentina Parrella\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/5e59d6ee887eb3eafd7887d214ff1a09\"},\"headline\":\"Digital Therapeutics: the next frontier in chronic disease management\",\"datePublished\":\"2024-11-27T15:19:28+00:00\",\"dateModified\":\"2024-12-03T16:26:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/digital-health\/digital-therapies\/digital-therapeutics-the-next-frontier-in-chronic-disease-management\/\"},\"wordCount\":578,\"image\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/digital-health\/digital-therapies\/digital-therapeutics-the-next-frontier-in-chronic-disease-management\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/12\/AdobeStock_1108713087-scaled.jpeg\",\"articleSection\":[\"Digital Therapies\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/digital-health\/digital-therapies\/digital-therapeutics-the-next-frontier-in-chronic-disease-management\/\",\"url\":\"https:\/\/makingpharmaindustry.it\/en\/digital-health\/digital-therapies\/digital-therapeutics-the-next-frontier-in-chronic-disease-management\/\",\"name\":\"Digital Therapeutics: the next frontier in chronic disease management - MakingPharmaIndustry\",\"isPartOf\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/digital-health\/digital-therapies\/digital-therapeutics-the-next-frontier-in-chronic-disease-management\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/digital-health\/digital-therapies\/digital-therapeutics-the-next-frontier-in-chronic-disease-management\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/12\/AdobeStock_1108713087-scaled.jpeg\",\"datePublished\":\"2024-11-27T15:19:28+00:00\",\"dateModified\":\"2024-12-03T16:26:07+00:00\",\"author\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/5e59d6ee887eb3eafd7887d214ff1a09\"},\"description\":\"Digital therapeutics (DTx) and health technologies are empowering patients with advanced tools for self-management, monitoring, and treatment\",\"breadcrumb\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/digital-health\/digital-therapies\/digital-therapeutics-the-next-frontier-in-chronic-disease-management\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/makingpharmaindustry.it\/en\/digital-health\/digital-therapies\/digital-therapeutics-the-next-frontier-in-chronic-disease-management\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/digital-health\/digital-therapies\/digital-therapeutics-the-next-frontier-in-chronic-disease-management\/#primaryimage\",\"url\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/12\/AdobeStock_1108713087-scaled.jpeg\",\"contentUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/12\/AdobeStock_1108713087-scaled.jpeg\",\"width\":2560,\"height\":1435,\"caption\":\"A digital representation of a virus outbreak with rising data trends, symbolizing the impact of COVID-19 on health metrics.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/digital-health\/digital-therapies\/digital-therapeutics-the-next-frontier-in-chronic-disease-management\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/makingpharmaindustry.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Digital Therapeutics: the next frontier in chronic disease management\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#website\",\"url\":\"https:\/\/makingpharmaindustry.it\/en\/\",\"name\":\"MakingPharmaIndustry\",\"description\":\"Luogo di incontro\u00a0per approfondire e discutere le pi\u00f9 importanti tematiche del mondo Pharma, dalla ricerca e sviluppo al manufacturing, dal mercato al business\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/makingpharmaindustry.it\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/5e59d6ee887eb3eafd7887d214ff1a09\",\"name\":\"Valentina Parrella\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g\",\"caption\":\"Valentina Parrella\"},\"url\":\"https:\/\/makingpharmaindustry.it\/en\/author\/valentina-parrella\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Digital Therapeutics: the next frontier in chronic disease management - MakingPharmaIndustry","description":"Digital therapeutics (DTx) and health technologies are empowering patients with advanced tools for self-management, monitoring, and treatment","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/makingpharmaindustry.it\/en\/digital-health\/digital-therapies\/digital-therapeutics-the-next-frontier-in-chronic-disease-management\/","og_locale":"en_US","og_type":"article","og_title":"Digital Therapeutics: the next frontier in chronic disease management - MakingPharmaIndustry","og_description":"Digital therapeutics (DTx) and health technologies are empowering patients with advanced tools for self-management, monitoring, and treatment","og_url":"https:\/\/makingpharmaindustry.it\/en\/digital-health\/digital-therapies\/digital-therapeutics-the-next-frontier-in-chronic-disease-management\/","og_site_name":"MakingPharmaIndustry","article_published_time":"2024-11-27T15:19:28+00:00","article_modified_time":"2024-12-03T16:26:07+00:00","og_image":[{"width":2560,"height":1435,"url":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/12\/AdobeStock_1108713087-scaled.jpeg","type":"image\/jpeg"}],"author":"Valentina Parrella","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Valentina Parrella","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/makingpharmaindustry.it\/en\/digital-health\/digital-therapies\/digital-therapeutics-the-next-frontier-in-chronic-disease-management\/#article","isPartOf":{"@id":"https:\/\/makingpharmaindustry.it\/en\/digital-health\/digital-therapies\/digital-therapeutics-the-next-frontier-in-chronic-disease-management\/"},"author":{"name":"Valentina Parrella","@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/5e59d6ee887eb3eafd7887d214ff1a09"},"headline":"Digital Therapeutics: the next frontier in chronic disease management","datePublished":"2024-11-27T15:19:28+00:00","dateModified":"2024-12-03T16:26:07+00:00","mainEntityOfPage":{"@id":"https:\/\/makingpharmaindustry.it\/en\/digital-health\/digital-therapies\/digital-therapeutics-the-next-frontier-in-chronic-disease-management\/"},"wordCount":578,"image":{"@id":"https:\/\/makingpharmaindustry.it\/en\/digital-health\/digital-therapies\/digital-therapeutics-the-next-frontier-in-chronic-disease-management\/#primaryimage"},"thumbnailUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/12\/AdobeStock_1108713087-scaled.jpeg","articleSection":["Digital Therapies"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/makingpharmaindustry.it\/en\/digital-health\/digital-therapies\/digital-therapeutics-the-next-frontier-in-chronic-disease-management\/","url":"https:\/\/makingpharmaindustry.it\/en\/digital-health\/digital-therapies\/digital-therapeutics-the-next-frontier-in-chronic-disease-management\/","name":"Digital Therapeutics: the next frontier in chronic disease management - MakingPharmaIndustry","isPartOf":{"@id":"https:\/\/makingpharmaindustry.it\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/makingpharmaindustry.it\/en\/digital-health\/digital-therapies\/digital-therapeutics-the-next-frontier-in-chronic-disease-management\/#primaryimage"},"image":{"@id":"https:\/\/makingpharmaindustry.it\/en\/digital-health\/digital-therapies\/digital-therapeutics-the-next-frontier-in-chronic-disease-management\/#primaryimage"},"thumbnailUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/12\/AdobeStock_1108713087-scaled.jpeg","datePublished":"2024-11-27T15:19:28+00:00","dateModified":"2024-12-03T16:26:07+00:00","author":{"@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/5e59d6ee887eb3eafd7887d214ff1a09"},"description":"Digital therapeutics (DTx) and health technologies are empowering patients with advanced tools for self-management, monitoring, and treatment","breadcrumb":{"@id":"https:\/\/makingpharmaindustry.it\/en\/digital-health\/digital-therapies\/digital-therapeutics-the-next-frontier-in-chronic-disease-management\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/makingpharmaindustry.it\/en\/digital-health\/digital-therapies\/digital-therapeutics-the-next-frontier-in-chronic-disease-management\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/makingpharmaindustry.it\/en\/digital-health\/digital-therapies\/digital-therapeutics-the-next-frontier-in-chronic-disease-management\/#primaryimage","url":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/12\/AdobeStock_1108713087-scaled.jpeg","contentUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/12\/AdobeStock_1108713087-scaled.jpeg","width":2560,"height":1435,"caption":"A digital representation of a virus outbreak with rising data trends, symbolizing the impact of COVID-19 on health metrics."},{"@type":"BreadcrumbList","@id":"https:\/\/makingpharmaindustry.it\/en\/digital-health\/digital-therapies\/digital-therapeutics-the-next-frontier-in-chronic-disease-management\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/makingpharmaindustry.it\/en\/"},{"@type":"ListItem","position":2,"name":"Digital Therapeutics: the next frontier in chronic disease management"}]},{"@type":"WebSite","@id":"https:\/\/makingpharmaindustry.it\/en\/#website","url":"https:\/\/makingpharmaindustry.it\/en\/","name":"MakingPharmaIndustry","description":"Luogo di incontro\u00a0per approfondire e discutere le pi\u00f9 importanti tematiche del mondo Pharma, dalla ricerca e sviluppo al manufacturing, dal mercato al business","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/makingpharmaindustry.it\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/5e59d6ee887eb3eafd7887d214ff1a09","name":"Valentina Parrella","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g","caption":"Valentina Parrella"},"url":"https:\/\/makingpharmaindustry.it\/en\/author\/valentina-parrella\/"}]}},"_links":{"self":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/21592","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/comments?post=21592"}],"version-history":[{"count":6,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/21592\/revisions"}],"predecessor-version":[{"id":21602,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/21592\/revisions\/21602"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/media\/21588"}],"wp:attachment":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/media?parent=21592"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/categories?post=21592"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/tags?post=21592"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}